[x] The term “GP system suppliers” is used throughout the website. I’m not sure who that refers to. Does this mean providers and/or consumers? Shouldn’t we be using the terms GP Principal Clinical Systems providers and/or Consumer suppliers (they were the terms that were agreed after I circulated the proposed pathways in June)
[x] We’ve already discussed having some IG principles. Do we need anything on Clinical Safety/ Assurance?
BD: we are in discussions with assurance to define the approach. The outcome of this will be further content on the test and assure section of site
[x ] In the Introduction it mentions the FHIR APIs – I know they’re in the diagram below but I think it would also be worth calling out all the APIs/capabilities at a high level.
BD: This feels like it may be something for the corporate site - a summary which sits above both the FHIR API and the messaging sites and links to both.
[x] The Introduction also says that the audience is Message senders and Message receivers (NHS organisations). I thought this site was not for NHS organisations but for suppliers who might wish to develop APIs.
[x] Do we need anything on Technical Accreditation/Conformance (HSCN/IG Toolkit/other reqts)?
BD: we are in discussions with assurance to define the approach. The outcome of this will be further content on the test and assure section of site
[x ] The terms “Registered practice GP system” and “Federated practice GP system” are used. Can we add definitions to the Glossary?
These terms are only used in the federated consulation summary use case. They are now defined at in the overview page for this use case
[x] Have Service Ops/Solutions Assurance confirmed how this will be used with the TOM?
BD: we are in discussions with assurance to define the approach.
The following questions were raised by Alison:
[x] The term “GP system suppliers” is used throughout the website. I’m not sure who that refers to. Does this mean providers and/or consumers? Shouldn’t we be using the terms GP Principal Clinical Systems providers and/or Consumer suppliers (they were the terms that were agreed after I circulated the proposed pathways in June)
[x] We’ve already discussed having some IG principles. Do we need anything on Clinical Safety/ Assurance?
BD: we are in discussions with assurance to define the approach. The outcome of this will be further content on the test and assure section of site
BD: This feels like it may be something for the corporate site - a summary which sits above both the FHIR API and the messaging sites and links to both.
[x] The Introduction also says that the audience is Message senders and Message receivers (NHS organisations). I thought this site was not for NHS organisations but for suppliers who might wish to develop APIs.
[x] Do we need anything on Technical Accreditation/Conformance (HSCN/IG Toolkit/other reqts)?
BD: we are in discussions with assurance to define the approach. The outcome of this will be further content on the test and assure section of site
These terms are only used in the federated consulation summary use case. They are now defined at in the overview page for this use case
BD: we are in discussions with assurance to define the approach.